HeartSciences (HSCSW) Gross Margin (2021 - 2025)

HeartSciences (HSCSW) has reported Gross Margin for 5 consecutive years, with 58.33% the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Gross Margin changed N/A year-over-year to 58.33%; the trailing twelve-month figure through Apr 2026 stood at 57.92% (down 827.0% YoY), and the FY2026 full-year result was 59.06%, up 228.0% from the prior year.
• Gross Margin declined to 58.33% in Q4 2025 per HSCSW's latest filing, from 60.0% in the prior quarter.
• Across five years, Gross Margin topped out at 69.15% in Q2 2022 and bottomed at 23.09% in Q3 2021.
• Historically, Gross Margin has averaged 56.36% across 5 years, with a median of 60.51% in 2025.
• The sharpest annual moves came in 2022 and 2023: Gross Margin jumped 1329 bps in 2022, then plunged 781 bps in 2023.
• Over 5 years, Gross Margin stood at 23.09% in 2021, then soared by 58 bps to 36.38% in 2022, then surged by 68 bps to 61.03% in 2023, then grew by 13 bps to 68.97% in 2024, then declined by 15 bps to 58.33% in 2025.
• According to Business Quant data, Gross Margin over the past three periods registered 58.33%, 60.0%, and 56.78% for Q4 2025, Q3 2025, and Q2 2025 respectively.